Detalhe da pesquisa
1.
DNA polymerase θ protects leukemia cells from metabolically induced DNA damage.
Blood
; 141(19): 2372-2389, 2023 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36580665
2.
Long-term outcomes for ibrutinib-rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial.
Blood
; 140(2): 112-120, 2022 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35427411
3.
Enhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemia.
Blood
; 139(24): 3519-3531, 2022 06 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35192684
4.
Obesity in adult acute myeloid leukemia is not associated with inferior response or survival even when dose capping anthracyclines: An ECOG-ACRIN analysis.
Cancer
; 129(16): 2479-2490, 2023 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37185873
5.
Measurable residual disease does not preclude prolonged progression-free survival in CLL treated with ibrutinib.
Blood
; 138(26): 2810-2827, 2021 12 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34407545
6.
Degradation of Janus kinases in CRLF2-rearranged acute lymphoblastic leukemia.
Blood
; 138(23): 2313-2326, 2021 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34110416
7.
Molecular classification improves risk assessment in adult BCR-ABL1-negative B-ALL.
Blood
; 138(11): 948-958, 2021 09 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33895809
8.
Prognostic effect of gender on outcome of treatment for adults with acute myeloid leukaemia.
Br J Haematol
; 194(2): 309-318, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34145576
9.
A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403.
Blood
; 133(14): 1548-1559, 2019 04 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30658992
10.
Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemia.
Nature
; 521(7552): 357-61, 2015 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-25799995
11.
At three years, patients with acute lymphoblastic leukaemia are still at risk for relapse. Results of the international MRC UKALLXII/ECOG E2993 trial.
Br J Haematol
; 191(1): 37-43, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32220069
12.
Contrasting roles of histone 3 lysine 27 demethylases in acute lymphoblastic leukaemia.
Nature
; 514(7523): 513-7, 2014 Oct 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-25132549
13.
Synergistic antileukemic therapies in NOTCH1-induced T-ALL.
Proc Natl Acad Sci U S A
; 114(8): 2006-2011, 2017 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-28174276
14.
A randomized trial of three novel regimens for recurrent acute myeloid leukemia demonstrates the continuing challenge of treating this difficult disease.
Am J Hematol
; 94(1): 111-117, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30370956
15.
Pentostatin, Cyclophosphamide, and Rituximab Followed by Alemtuzumab for Relapsed or Refractory Chronic Lymphocytic Leukemia: A Phase 2 Trial of the ECOG-Acrin Cancer Research Group (E2903).
Acta Haematol
; 142(4): 224-232, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31336367
16.
Benefit of high-dose daunorubicin in AML induction extends across cytogenetic and molecular groups.
Blood
; 127(12): 1551-8, 2016 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-26755712
17.
Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical setting.
Blood
; 127(24): 3004-14, 2016 06 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-26966091
18.
Very poor long-term survival in past and more recent studies for relapsed AML patients: The ECOG-ACRIN experience.
Am J Hematol
; 93(8): 1074-1081, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29905379
19.
Tumor-specific HSP90 inhibition as a therapeutic approach in JAK-mutant acute lymphoblastic leukemias.
Blood
; 126(22): 2479-83, 2015 Nov 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-26443624
20.
A genome-wide association study of susceptibility to acute lymphoblastic leukemia in adolescents and young adults.
Blood
; 125(4): 680-6, 2015 Jan 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-25468567